LSTA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Lisata Therapeutics Inc (LSTA) is not a good buy for a beginner investor with a long-term strategy at this time. The company has weak financial performance, no positive trading trends, and no significant catalysts to drive growth. Additionally, technical indicators do not support a strong entry point, and there are no proprietary trading signals to suggest immediate action.
The MACD is below 0 and negatively contracting, indicating bearish momentum. RSI is neutral at 31.948, and moving averages are converging, suggesting no clear trend. The stock is trading near its support level (S1: 2.986), but there is no strong indication of a reversal or breakout.
NULL identified. No recent news or significant trading trends from hedge funds, insiders, or congress members.
The company's financial performance is poor, with a 90% YoY revenue drop, significant net income losses, and declining EPS. Technical indicators show bearish momentum, and there is no recent news or events to drive positive sentiment.
In Q4 2025, revenue dropped by 90% YoY to $100,000. Net income fell to -$2,954,000, down 35.92% YoY. EPS declined by 38.18% YoY to -0.34. Despite a stable gross margin of 100%, overall financials are weak and show no signs of growth.
No data on analyst ratings or price target changes is available.
